Skip to Main Content
Table 2

BRAF gene mutation in thyroid neoplasms

No.Positive (%)P
Tumor type    
 Follicular adenoma 18 0 (0%)  
 Papillary carcinoma 56 21 (38%) 0.006 
Tumor stage (PTC)    
 T1 10 4 (40%) >0.05 
 T2 35 13 (37%)  
 T3-T4 11 4 (36%)  
Age (PTC)    
 <40 years 23 6 (26%)  
 >40 years 33 15 (46%) 0.233 
Gender (PTC)    
 Male 14 9 (64%)  
 Female 42 12 (27%) 0.038 
Node metastasis (PTC)    
 Yes 13 7 (54%)  
 No 43 14 (32%) 0.288 
No.Positive (%)P
Tumor type    
 Follicular adenoma 18 0 (0%)  
 Papillary carcinoma 56 21 (38%) 0.006 
Tumor stage (PTC)    
 T1 10 4 (40%) >0.05 
 T2 35 13 (37%)  
 T3-T4 11 4 (36%)  
Age (PTC)    
 <40 years 23 6 (26%)  
 >40 years 33 15 (46%) 0.233 
Gender (PTC)    
 Male 14 9 (64%)  
 Female 42 12 (27%) 0.038 
Node metastasis (PTC)    
 Yes 13 7 (54%)  
 No 43 14 (32%) 0.288 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept